CUSIP 30052C107 · who reports it, how much, and how much it matters to them
17 of the 720 hedge fund managers we track reported shares of Evolus, Inc. (Nasdaq: EOLS) on Form 13F for 30 June 2026. Between them they reported USD 101m. The largest position belongs to Braidwell, at USD 22m. The manager with the most riding on it is Awh Capital, where it is 3.0% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Braidwell12 funds on PPLI.com | USD 22m | 0.8% |
| 2 | Perceptive Advisors6 funds on PPLI.com | USD 17m | 0.3% |
| 3 | Millennium Management6 funds on PPLI.com | USD 12m | 0.0% |
| 4 | POINT72 Asset Management17 funds on PPLI.com | USD 10m | 0.0% |
| 5 | Armistice Capital1 fund on PPLI.com | USD 10m | 0.1% |
| 6 | Awh Capital1 fund on PPLI.com | USD 8.7m | 3.0% |
| 7 | Soviero Asset Management1 fund on PPLI.com | USD 5.3m | 2.2% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 3.5m | 0.0% |
| 9 | CM Management1 fund on PPLI.com | USD 2.8m | 1.8% |
| 10 | D. E. Shaw & Co.15 funds on PPLI.com | USD 2.3m | 0.0% |
| 11 | Renaissance Technologies13 funds on PPLI.com | USD 2.1m | 0.0% |
| 12 | Walleye Capital8 funds on PPLI.com | USD 1.8m | 0.0% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 1.4m | 0.0% |
| 14 | Exoduspoint Capital Management7 funds on PPLI.com | USD 534,000 | 0.0% |
| 15 | Aquatic Capital Management3 funds on PPLI.com | USD 423,000 | 0.0% |
| 16 | Prelude Capital Management9 funds on PPLI.com | USD 356,000 | 0.0% |
| 17 | Tudor Investment Corporation10 funds on PPLI.com | USD 219,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Awh Capital | USD 8.7m | 3.0% |
| 2 | Soviero Asset Management | USD 5.3m | 2.2% |
| 3 | CM Management | USD 2.8m | 1.8% |
| 4 | Braidwell | USD 22m | 0.8% |
| 5 | Perceptive Advisors | USD 17m | 0.3% |
| 6 | Armistice Capital | USD 10m | 0.1% |
| 7 | Prelude Capital Management | USD 356,000 | 0.0% |
| 8 | Aquatic Capital Management | USD 423,000 | 0.0% |
| 9 | POINT72 Asset Management | USD 10m | 0.0% |
| 10 | Walleye Capital | USD 1.8m | 0.0% |
Evolus, Inc. trades under the symbol EOLS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 30052C107.
17 of the 720 hedge fund managers PPLI.com tracks reported Evolus, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Braidwell (USD 22m), Perceptive Advisors (USD 17m), Millennium Management (USD 12m), POINT72 Asset Management (USD 10m) and Armistice Capital (USD 10m).
17 managers in our coverage reported it, and between them they run 149 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Awh Capital, where the position was 3.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Evolus, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.